Unstable angina pathophysiology centers on a sudden mismatch between myocardial oxygen supply and demand, typically triggered by the acute rupture or erosion of a coronary atherosclerotic plaque. This event initiates a cascade of platelet activation, fibrin deposition, and vasoconstriction, culminating in a dynamic and often unpredictable reduction in coronary blood flow. Unlike stable angina, the ischemic discomfort arises at rest or with minimal exertion, signaling a heightened risk of imminent myocardial infarction. The underlying pathology is not merely a static obstruction but an evolving process involving inflammation, thrombosis, and endothelial dysfunction.
Plaque Instability and Thrombosis
The cornerstone of unstable angina pathophysiology is the vulnerable plaque, a complex lesion characterized by a large lipid-rich necrotic core, a thin fibrous cap, and extensive inflammation. Macrophages infiltrating the plaque secrete enzymes that degrade the extracellular matrix, particularly collagen, weakening the cap’s integrity. When the cap ruptures, the highly thrombogenic lipid core and tissue factor are exposed to circulating blood. This triggers rapid platelet adhesion, activation, and aggregation, forming a non-occlusive thrombus that significantly narrows the already compromised arterial lumen.
Dynamic Coronary Obstruction
Unlike the fixed stenosis seen in stable angina, the thrombus formed in unstable angina is often transient and intermittent. This dynamic obstruction leads to fluctuating patterns of myocardial ischemia. Coronary vasospasm may further exacerbate the reduction in flow, compressing the vessel and contributing to the clinical variability of symptoms. The pathophysiological interplay between thrombosis and vasospasm creates a unpredictable ischemic environment, where even minor changes in heart rate or blood pressure can precipitate severe angina.
Role of Inflammation and Endothelial Dysfunction
Systemic inflammation plays a pivotal role in the progression from stable to unstable coronary disease. Elevated levels of inflammatory markers like C-reactive protein are associated with plaque vulnerability. Endothelial dysfunction, often an early event, impairs the normal regulation of vascular tone, favoring vasoconstriction and thrombosis. The loss of nitric oxide bioavailability and reduced production of prostacyclin disrupt the balance between vasodilation and vasoconstriction, creating a pro-thrombotic and pro-inflammatory milieu that underpins acute coronary syndromes.
Cellular and Molecular Mediators
At the cellular level, the interaction between activated platelets and the endothelium involves multiple adhesion molecules. Integrins such as αIIbβ3 on platelets bind to fibrinogen, facilitating platelet cross-linking and thrombus formation. Simultaneously, the expression of selectins and chemokine receptors on endothelial cells promotes the rolling and adhesion of leukocytes, particularly monocytes, which infiltrate the plaque and perpetuate the inflammatory cascade. This intricate network of molecular events is central to the rapid onset of ischemia in unstable angina.
Clinical Manifestations of Ischemia
The pathophysiological events described manifest clinically as rest angina, new-onset severe exertional angina, or angina that is accelerating in frequency, duration, or intensity. The ischemia results in the characteristic retrosternal chest pain due to the activation of afferent nerve fibers in the myocardium. Autonomic nervous system activation leads to symptoms such as diaphoresis, nausea, and shortness of breath. Recognizing these patterns is crucial, as they directly correlate with the severity and unpredictability of the underlying coronary pathology.
Diagnostic and Prognostic Implications
Diagnosis relies on correlating the clinical presentation with ECG changes and biomarker elevation, primarily to rule out myocardial infarction. However, the pathophysiology of unstable angina is defined by myocardial ischemia without significant cell death, explaining the absence of elevated cardiac troponin. This distinction is critical for risk stratification. Patients with unstable angina carry a high short-term risk of progression to myocardial infarction or death, necessitating aggressive medical therapy and often urgent revascularization to address the underlying coronary anatomy.
